Mary J. Waskerwitz

1.2k total citations
22 papers, 891 citations indexed

About

Mary J. Waskerwitz is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary J. Waskerwitz has authored 22 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 15 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary J. Waskerwitz's work include Acute Lymphoblastic Leukemia research (15 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Glioma Diagnosis and Treatment (3 papers). Mary J. Waskerwitz is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Glioma Diagnosis and Treatment (3 papers). Mary J. Waskerwitz collaborates with scholars based in United States and Switzerland. Mary J. Waskerwitz's co-authors include G. Denman Hammond, Richard T. O’Brien, Harland N. Sather, D G Tubergen, Gerald S. Gilchrist, Peter F. Coccia, Leslie L. Robison, Thomas A. Kaleita, James A. Stehbens and Robert B. Noll and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mary J. Waskerwitz

21 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary J. Waskerwitz United States 14 592 575 190 133 113 22 891
Robert C. Trueworthy United States 15 365 0.6× 326 0.6× 195 1.0× 83 0.6× 111 1.0× 28 839
Q. Liu United States 3 359 0.6× 417 0.7× 148 0.8× 112 0.8× 94 0.8× 3 750
Robison Ll United States 7 356 0.6× 350 0.6× 132 0.7× 130 1.0× 83 0.7× 12 805
Alison Leiper United Kingdom 18 441 0.7× 488 0.8× 423 2.2× 122 0.9× 52 0.5× 27 983
Marcia Leonard United States 12 399 0.7× 388 0.7× 128 0.7× 63 0.5× 114 1.0× 21 794
Keiko Asami Japan 18 314 0.5× 376 0.7× 227 1.2× 93 0.7× 259 2.3× 53 943
Leslie Robison United States 7 292 0.5× 357 0.6× 65 0.3× 101 0.8× 56 0.5× 8 701
Audrey Contet France 15 324 0.5× 367 0.6× 189 1.0× 54 0.4× 95 0.8× 29 623
Hiroko Inada Japan 17 236 0.4× 321 0.6× 111 0.6× 82 0.6× 156 1.4× 49 817
Briana C. Patterson United States 13 273 0.5× 385 0.7× 96 0.5× 92 0.7× 86 0.8× 33 755

Countries citing papers authored by Mary J. Waskerwitz

Since Specialization
Citations

This map shows the geographic impact of Mary J. Waskerwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary J. Waskerwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary J. Waskerwitz more than expected).

Fields of papers citing papers by Mary J. Waskerwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary J. Waskerwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary J. Waskerwitz. The network helps show where Mary J. Waskerwitz may publish in the future.

Co-authorship network of co-authors of Mary J. Waskerwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mary J. Waskerwitz. A scholar is included among the top collaborators of Mary J. Waskerwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary J. Waskerwitz. Mary J. Waskerwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiley, Frances M., Kathy Ruccione, Ida M. Moore, et al.. (1999). Parents' Perceptions of Randomization in Pediatric Clinical Trials. Cancer Practice. 7(5). 248–256. 47 indexed citations
2.
3.
4.
Noll, Robert B., Thomas A. Kaleita, James A. Stehbens, et al.. (1997). Behavioral Adkjustmnet and Social Functioning of Long-Term, Survivors of Childhood Leukemia: Parent and Teacher Reports. Journal of Pediatric Psychology. 22(6). 827–841. 57 indexed citations
5.
MacLean, William E., Robert B. Noll, James A. Stehbens, et al.. (1995). Neuropsychological Effects of Cranial Irradiation in Young Children With Acute Lymphoblastic Leukemia 9 Months After Diagnosis. Archives of Neurology. 52(2). 156–160. 32 indexed citations
6.
Tubergen, D G, John W. Cullen, James M. Boyett, et al.. (1994). Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group study.. Journal of Clinical Oncology. 12(2). 273–278. 33 indexed citations
7.
Ruccione, Kathleen S., et al.. (1994). What Caused My Child's Cancer? Parents' Responses to an Epidemiology Study of Childhood Cancer. Journal of Pediatric Oncology Nursing. 11(2). 71–84. 21 indexed citations
8.
Stehbens, James A., William E. MacLean, Thomas A. Kaleita, et al.. (1994). Effects of CNS Prophylaxis on the Neuropsychological Performance of Children With Acute Lymphoblastic Leukemia: Nine Months Postdiagnosis. Children s Health Care. 23(4). 231–250. 11 indexed citations
9.
Tubergen, D G, Harland N. Sather, P. Coccia, et al.. (1994). Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.. Journal of Clinical Oncology. 12(12). 2594–2600. 48 indexed citations
10.
Buckley, Jonathan D., Kathleen S. Ruccione, H N Sather, et al.. (1994). Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group.. PubMed. 8(5). 856–64. 68 indexed citations
11.
Olshan, Andrew F., Norman E. Breslow, John M. Falletta, et al.. (1993). Risk factors for Wilms tumor: Report from the national Wilms tumor study. Cancer. 72(3). 938–944. 70 indexed citations
12.
Tubergen, D G, Gerald S. Gilchrist, Richard T. O’Brien, et al.. (1993). Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.. Journal of Clinical Oncology. 11(3). 520–526. 107 indexed citations
13.
Tubergen, D G, Gerald S. Gilchrist, Richard T. O’Brien, et al.. (1993). Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.. Journal of Clinical Oncology. 11(3). 527–537. 167 indexed citations
14.
Freyer, David R., et al.. (1993). Brief unconscious sedation for painful pediatric oncology procedures. Intravenous methohexital with appropriate monitoring is safe and effective.. PubMed. 15(4). 370–6. 25 indexed citations
15.
Stehbens, James A., Thomas A. Kaleita, Robert B. Noll, et al.. (1991). CNS prophylaxis of childhood leukemia: What are the long-term neurological, neuropsychological, and behavioral effects?. Neuropsychology Review. 2(2). 147–177. 55 indexed citations
16.
17.
Olshan, Andrew F., N. E. Breslow, Janet R. Daling, et al.. (1990). Wilms' tumor and paternal occupation.. PubMed. 50(11). 3212–7. 39 indexed citations
18.
Fergusson, Jean, et al.. (1987). Time required to assess children for the late effects of treatment. Cancer Nursing. 10(6). 300???310–300???310. 9 indexed citations
19.
Waskerwitz, Mary J. & Kathy Ruccione. (1985). An Overview of Cancer in Children in the 1980s. Nursing Clinics of North America. 20(1). 5–29. 7 indexed citations
20.
Waskerwitz, Mary J.. (1984). Special nursing care for children receiving chemotherapy.. PubMed. 1(1). 16–25.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert C. Trueworthy Breakdown of academic impact, for papers by Q. Liu Breakdown of academic impact, for papers by Robison Ll Breakdown of academic impact, for papers by Alison Leiper Breakdown of academic impact, for papers by Marcia Leonard Breakdown of academic impact, for papers by Keiko Asami Breakdown of academic impact, for papers by Leslie Robison Breakdown of academic impact, for papers by Audrey Contet Breakdown of academic impact, for papers by Hiroko Inada Breakdown of academic impact, for papers by Briana C. Patterson
Rankless by CCL
2026